Skip to main content
Livermore
Livermore
ZHEN

Alliancebernstein L.P.

SEC CIK
0001109448
Latest filing
Aug 14, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by Alliancebernstein L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of FATE by Alliancebernstein L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−187,700−100.0%Sold outHolders
Q1 2026187,700$184.4K<0.1%00.0%UnchangedHolders
Q4 2025187,700$184.4K<0.1%00.0%UnchangedHolders
Q3 2025187,700$236.5K<0.1%00.0%UnchangedHolders
Q2 2025187,700$210.2K<0.1%+41,120+28.1%AddedHolders
Q1 2025146,580$115.8K<0.1%00.0%UnchangedHolders
Q4 2024146,580$241.9K<0.1%00.0%UnchangedHolders
Q3 2024146,580$513.0K<0.1%00.0%UnchangedHolders
Q2 2024146,580$480.8K<0.1%+46,200+46.0%AddedHolders
Q1 2024100,380$736.8K<0.1%−60,380−37.6%ReducedHolders
Q4 2023160,760$601.2K<0.1%−800−0.5%ReducedHolders
Q3 2023161,560$342.5K<0.1%+34,430+27.1%AddedHolders
Q2 2023127,130$605.1K<0.1%+25,330+24.9%AddedHolders
Q1 2023101,800$580.3K<0.1%−200,000−66.3%ReducedHolders
Q4 2022301,800$3.05M<0.1%+200,000+196.5%AddedHolders
Q3 2022101,800$2.28M<0.1%−39,990−28.2%ReducedHolders
Q2 2022141,790$3.51M<0.1%−157−0.1%ReducedHolders
Q1 2022141,947$5.50M<0.1%+357+0.3%AddedHolders
Q4 2021141,590$8.28M<0.1%00.0%UnchangedHolders
Q3 2021141,590$8.39M<0.1%−600−0.4%ReducedHolders
Q2 2021142,190$12.3M<0.1%+13,020+10.1%AddedHolders
Q1 2021129,170$10.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.